Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

ANCN

Anchiano Therapeutics (ANCN)

Anchiano Therapeutics Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ANCN
FechaHoraFuenteTítuloSímboloCompañía
16/06/202315:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
19/05/202315:07Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
11/05/202305:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ANCNAnchiano Therapeutics Ltd
23/03/202306:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANCNAnchiano Therapeutics Ltd
29/11/202205:17Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/11/202215:04Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/08/202215:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ANCNAnchiano Therapeutics Ltd
31/05/202209:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ANCNAnchiano Therapeutics Ltd
28/04/202215:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ANCNAnchiano Therapeutics Ltd
25/04/202215:20Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ANCNAnchiano Therapeutics Ltd
03/09/202115:05Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ANCNAnchiano Therapeutics Ltd
18/05/202105:08Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ANCNAnchiano Therapeutics Ltd
29/04/202105:23Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/04/202116:28Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/04/202115:04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ANCNAnchiano Therapeutics Ltd
30/03/202106:49Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ANCNAnchiano Therapeutics Ltd
26/03/202115:07Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ANCNAnchiano Therapeutics Ltd
26/03/202107:10Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/03/202116:54GlobeNewswire Inc.Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private FinancingNASDAQ:ANCNAnchiano Therapeutics Ltd
09/03/202115:28Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
09/03/202112:01Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:ANCNAnchiano Therapeutics Ltd
10/02/202112:20Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
13/01/202108:32Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/12/202008:00GlobeNewswire Inc.Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger AgreementNASDAQ:ANCNAnchiano Therapeutics Ltd
21/11/201916:01Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
18/11/201905:43Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
24/04/201916:22Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
25/03/201915:18Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ANCNAnchiano Therapeutics Ltd
14/03/201907:16GlobeNewswire Inc.Anchiano Therapeutics Initiates Process to Voluntarily Delist its Ordinary Shares from the Tel Aviv Stock ExchangeNASDAQ:ANCNAnchiano Therapeutics Ltd
13/02/201907:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:ANCNAnchiano Therapeutics Ltd
 Showing the most relevant articles for your search:NASDAQ:ANCN

Su Consulta Reciente

Delayed Upgrade Clock